Feb 12, 2026 07:11AM
Feb 10, 2026 04:12PM
Feb 10, 2026 04:05PM
Jan 27, 2026 04:05PM
Jan 12, 2026 04:05AM
Jan 11, 2026 04:00PM
Dec 12, 2025 10:31AM GI Cancer Immunotherapy Breakthroughs Signal New Treatment Era
Nov 5, 2025 01:55AM
Nov 4, 2025 04:17PM
Nov 4, 2025 04:05PM
Oct 21, 2025 04:05PM
Aug 12, 2025 06:40AM
Jul 29, 2025 09:20AM
Jul 28, 2025 04:09PM Exelixis (EXEL) Tops Q2 EPS by 11c, provides guidance
Jul 28, 2025 04:05PM
Jul 14, 2025 04:05PM
Jun 23, 2025 10:32AM
May 14, 2025 06:29AM
May 13, 2025 04:08PM
May 13, 2025 04:07PM
Apr 29, 2025 04:05PM Exelixis to Release First Quarter 2025 Financial Results on Tuesday, May 13, 2025
Apr 12, 2025 04:00AM
Mar 26, 2025 01:07PM
Feb 11, 2025 04:12PM
Feb 11, 2025 04:05PM
Jan 28, 2025 04:05PM
Jan 15, 2025 05:11PM
Jan 12, 2025 04:00PM Exelixis Announces Preliminary Fiscal Year 2024 Financial Results, Provides 2025 Financial Guidance and Outlines Key Priorities and Milestones for 2025
Oct 30, 2024 07:46AM
Oct 30, 2024 06:27AM
Oct 30, 2024 05:47AM
Oct 29, 2024 04:09PM
Oct 29, 2024 04:05PM
Oct 21, 2024 08:40AM
Oct 16, 2024 06:54AM Leerink Partners Reiterates Market Perform Rating on Exelixis (EXEL)
Oct 15, 2024 04:05PM
Aug 8, 2024 06:36AM
Aug 6, 2024 04:18PM
Aug 6, 2024 04:05PM
Jul 23, 2024 04:05PM
Apr 30, 2024 04:14PM
Apr 30, 2024 04:05PM Exelixis Announces First Quarter 2024 Financial Results and Provides Corporate Update
Apr 16, 2024 04:05PM
Feb 6, 2024 04:13PM
Feb 6, 2024 04:05PM
Jan 23, 2024 04:05PM
Jan 22, 2024 05:01PM
Jan 22, 2024 05:00PM
Jan 8, 2024 05:25AM Exelixis (EXEL) Reports Prelim FY23 Results, Issues 2024 Guidance
Jan 7, 2024 04:00PM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All